Skip to main content


Open for Submissions

Cancer therapy: KRAS targeted therapies

Guest Editors:
Biswarup Saha, MS, MTech, PhD, H Lee Moffitt Cancer Center & Research Institute, USA
Hitendra Singh Solanki, PhD, H. Lee Moffitt Cancer Center, USA

Submission Status: Open until 21 November 2024

Hyperthermia therapy for cancer

Guest Editors:
Arlene Oei, PhD, Amsterdam University Medical Center, The Netherlands
Tan Hwei Ching Grace, MBBS, MRCS, MMED, FRCS, Melissa Teo Surgery and The Surgical Oncology Clinic, Singapore

Submission Status: Open until 8 November 2024

Rare cancers

Guest Editors:
Atif A. Ahmed, MD, University of Washington, Seattle Children’s Hospital, United States
Bruna Samia Dalmasso, MD, PhD, Genetics of Rare Cancers, IRCCS Ospedale Policlinico San Martino, Italy

Submission Status: Open until 6 September 2024

Viral carcinogenesis

Guest Editor:
Julian Naipauer, PhD, Instituto de Fisiología, Biología Molecular y Neurociencias, Argentina

Submission Status: Open until 20 August 2024

Altered DNA repair mechanism in tumorigenesis

Guest Editors:
Kiyohiro Ando, MD, PhD, Saitama Cancer Center, Research Institute for Clinical Oncology, Japan
Pietro Di Fazio, PhD, Department of Visceral, Thoracic and Vascular Surgery, Philipps University Marburg, Germany
Zhihua Kang, PhD, Rutgers Cancer Institute of New Jersey, United States

Submission Status: Open until 20 July 2024

Applications of ctDNA and liquid biopsies in precision oncology

Guest Editors:
Claude Chelala, PhD, Queen Mary University of London, UK
Pasquale Pisapia, PhD, University of Naples Federico II, Italy

Submission Status: Open until 24 July 2024

Overcoming therapy resistance in prostate cancer

Guest Editors:
Holger Erb: Dresden University of Technology, Germany
Jacob Orme: Mayo Clinic, US

Submission Status: Open until 19 July 2024

Radiomics in cancer diagnosis and treatment

Guest Editors:
Archya Dasgupta: Tata Memorial Centre, Homi Bhabha National Institute, India
Qingtao Qiu: Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, China
Stefania Volpe: European Institute of Oncology (Istituto Europeo di Oncologia, IEO) IRCCS and University of Milan, Italy

Submission Status: Open until 17 July 2024

Cancer stem cells in the tumor microenvironment

Guest Editors:
Liang Qiao: Westmead Institute for Medical Research and The University of Sydney, Australia
Jenny Y. Wang: University of Sydney and Kolling Institute, Australia

Submission Status: Open until 9 July 2024

Diet and physical activity during and after cancer treatment

Guest Editors:
Nicolas H. Hart: University of Technology Sydney, Australia
Dominic O’Connor: University of Nottingham, United Kingdom

Submission Status: Open until 18 June 2024

Immunology and immunotherapy in solid cancers

Guest Editors:
Zachary C. Hartman: Duke University, United States
Daniel Smrz: Charles University and Motol University Hospital, Czech Republic

Submission Status: Open until 29 May 2024

New breakthroughs and future directions in the treatment of hematological malignancies

Guest Editors:
Ajay Abraham: Northwestern University, United States
Ahmet Emre Eşkazan: Istanbul University-Cerrahpaşa, Turkey

Submission Status: Open until 15 March 2024

Advances in personalized radiotherapy

Guest Editors:
Venkata SK. Manem: University of Quebec at Trois-Rivières, Canada
Farzad Taghizadeh-Hesary: Iran University of Medical Sciences, Iran

Submission Status: Open until 29 March 2024

Cancer metabolism

Guest Editors:
Elavarasan Subramani: The University of Texas M.D. Anderson Cancer Center, United States
Marija Traikovic-Arsic: German Cancer Consortium, Germany

Submission Status: Open until 6 March 2024


Cancer control in low- and middle-income countries

Guest Editors:
Cristina StefanInstitute of Global Health Equity Research, Rwanda
Shenglan TangDuke University, United States

Advances in pre-clinical cancer models

Guest Editors:
Ryan C. Fields: Washington University School of Medicine in St. Louis, USA
Anna Golebiewska: Luxembourg Institute of Health, Luxembourg

Extracellular vesicles in cancer progression

Guest Editors:
Orazio Fortunato:
Tumor Genomic Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Italy
Irina Matei: Weill Cornell Medicine, USA
Chunlin Ou: Xiangya Hospital, Central South University, China

Microbiome and cancer - Cross journal collection

Guest editors: Prof. Christopher Staley, Dr. Jacques Ravel and Dr. Sean Devlin. 

Targeted therapies - Cross journal collection

Guest Editors: Prof. Min Li and Dr. Yanis Boumber

Advances in CAR-T immunotherapy - Cross journal collection

Guest Editors: Profs Marko Radic, Djordje Atanackovic and Tim Luetkens


Cross journal collection
Translational Oncology
Guest editor: Prof Tommaso Dragani
Collection published: 28 July 2016


Cross journal collection
Roles of microRNAs and other noncoding RNAs in cancer
Collection published: 26 November 2014


Cross journal collection
Cancer bioinformatics: bioinformatic methods, network biomarkers and precision medicine
Edited by: Xiangdong Wang
Collection published: 1 May 2012


Thematic series
BMC Cancer's 10th anniversary special edition
BMC Cancer
Collection published: 30 November 2011

Annual Journal Metrics

  • 2022 Citation Impact
    3.8 - 2-year Impact Factor
    4.3 - 5-year Impact Factor
    1.166 - SNIP (Source Normalized Impact per Paper)
    1.137 - SJR (SCImago Journal Rank)

    2022 Speed
    26 days submission to first editorial decision for all manuscripts (Median)
    148 days submission to accept (Median)

    2022 Usage 
    11,097 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal